# OpenGamma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/opengamma

- Industry: Software
- Headquarters: London, UK
- Website: www.opengamma.com
- Total disclosed funding: $71M
- Latest round: Series F (Feb 1, 2022)
- Investors on record: 7

## About

OpenGamma Limited offers a sophisticated derivatives management platform, aiding financial institutions in optimizing trading, risk management, and treasury operations through enhanced transparency and efficiency. Founded in 2009 by Kirk Wylie, OpenGamma Limited is based in London, UK, and specializes in providing a comprehensive derivatives management platform. The company has accumulated 12 deals and raised a total of USD 74.45 million.In December 2025, Trading Technologies International, Inc., a portfolio company of Thoma Bravo and 7Ridge, acquired OpenGamma Limited from Allianz X, Accel, CME Ventures, Dawn Capital, Japan Exchange Group Inc, Euclid Opportunities, ICAP, First Mark Capital. As of December 2025, Peter Rippon is the CEO of the company.
OpenGamma focuses on a front-to-back derivatives management platform that enhances trading, risk management, treasury, and operational processes. Their products assist clients in managing capital requirements and reducing financing costs while offering transparency in margin models. The platform is utilized by diverse clients, including hedge funds and commodity trading firms, across Europe, North America, and Asia, helping them navigate regulatory changes and market volatility effectively.OpenGamma generates revenue primarily through subscription-based models, allowing clients to access a suite of analytics and management tools for derivatives trading. These tailored agreements include features such as forecasting, stress testing, and cash flow management, enabling clients to enhance their liquidity and margin management strategies. Although specific pricing details are undisclosed, the company’s core products are vital for supporting clients in derivatives trading.

## Funding rounds

- Series F, Feb 1, 2022, $21M — Allianz X
- Series E, Apr 3, 2019, $10M — Accel, Dawn Capital, CME Ventures
- Series D, Oct 5, 2016, $13M — Accel, ICAP, Euclid Opportunities
- Series C, Aug 8, 2012, $15M — Accel, FirstMark Capital, ICAP, Euclid Opportunities
- Series B, Dec 21, 2010, $6M — Accel, FirstMark Capital
- Series A, Aug 1, 2009, $6M — Accel

## Investors

- Accel (https://capitalatlas.ai/funds/accel) — Series A, Series B, Series C, Series D, Series E
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series B, Series C
- ICAP — Series C, Series D
- Euclid Opportunities — Series C, Series D
- Dawn Capital (https://capitalatlas.ai/funds/dawn-capital) — Series E
- CME Ventures (https://capitalatlas.ai/funds/cme-ventures) — Series E
- Allianz X (https://capitalatlas.ai/funds/allianz-x) — Series F